Factors associated with late risks of breast cancer-specific mortality in the SEER registry.
José Pablo LeoneCarlos T VallejoMichael J HassettJulieta LeoneNoah GrahamNabihah TayobRachel A FreedmanSara M TolaneyBernardo A LeoneEric P WinerNancy U LinPublished in: Breast cancer research and treatment (2021)
The risks of BCSM beyond 5 years, although different, remain important for both HR-positive and HR-negative BC. Strategies to prevent early and late recurrences are warranted.